Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(10):1522–1526. doi: 10.1054/bjoc.2001.2115

Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics

I Hadjiloucas 1, A P Gilmore 2, N J Bundred 1, C H Streuli 2
PMCID: PMC2363946  PMID: 11720439

Abstract

Apoptosis is of important significance in the pathogenesis of cancer. Many methods are available for the measurement of apoptosis but the ‘gold standard’ is to identify apoptotic cells by their morphological features using microscopy. Caspase 3 is a cytosolic enzyme that is activated only in cells committed to undergo apoptosis. The activation of caspase 3 precedes the development of the classical morphological features of apoptosis. Using immunohistochemistry with an antibody against the active form of caspase 3, the apoptotic index (AI) was measured in 116 samples of human breast tissue (22 normal/benign and 94 invasive carcinomas). The AI obtained by measuring caspase activation has a strong correlation with the AI derived by morphological assessment (r = 0.736, P < 0.01). The AI is higher in the invasive group than in the benign group (P = 0.008), and in invasive cancer high AI is associated with high tumour grade (P = 0.013), positive node status (P < 0.001) and negative steroid receptor status (P = 0.001 for ER; P = 0.004 for PR). No significant association is observed between AI and tumour size. Measurement of apoptosis by immunohistochemistry using an antibody against the active form of caspase 3 is therefore reliable and correlates strongly with morphological assessment. © 2001 Cancer Research Campaign  http://www.bjcancer.com

Keywords: apoptosis, caspase 3, breast cancer, mammary gland

Full Text

The Full Text of this article is available as a PDF (82.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashkenazi A., Dixit V. M. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999 Apr;11(2):255–260. doi: 10.1016/s0955-0674(99)80034-9. [DOI] [PubMed] [Google Scholar]
  2. Berardo M. D., Elledge R. M., de Moor C., Clark G. M., Osborne C. K., Allred D. C. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer. 1998 Apr 1;82(7):1296–1302. [PubMed] [Google Scholar]
  3. Frankfurt O. S., Robb J. A., Sugarbaker E. V., Villa L. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases. Clin Cancer Res. 1997 Mar;3(3):465–471. [PubMed] [Google Scholar]
  4. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gilmore A. P., Metcalfe A. D., Romer L. H., Streuli C. H. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol. 2000 Apr 17;149(2):431–446. doi: 10.1083/jcb.149.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995 May;21(5):1465–1468. doi: 10.1002/hep.1840210534. [DOI] [PubMed] [Google Scholar]
  7. Green D. R. Apoptotic pathways: the roads to ruin. Cell. 1998 Sep 18;94(6):695–698. doi: 10.1016/s0092-8674(00)81728-6. [DOI] [PubMed] [Google Scholar]
  8. Hall P. A. Assessing apoptosis: a critical survey. Endocr Relat Cancer. 1999 Mar;6(1):3–8. doi: 10.1677/erc.0.0060003. [DOI] [PubMed] [Google Scholar]
  9. Harn H. J., Shen K. L., Yueh K. C., Ho L. I., Yu J. C., Chiu S. C., Lee W. H. Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal-deoxynucleotidyl-transferase-mediated dUTP-FITC nick end labelling (TUNEL). Histopathology. 1997 Dec;31(6):534–539. doi: 10.1046/j.1365-2559.1997.3270906.x. [DOI] [PubMed] [Google Scholar]
  10. Hengartner M. O. The biochemistry of apoptosis. Nature. 2000 Oct 12;407(6805):770–776. doi: 10.1038/35037710. [DOI] [PubMed] [Google Scholar]
  11. Lipponen P., Aaltomaa S., Kosma V. M., Syrjänen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer. 1994;30A(14):2068–2073. doi: 10.1016/0959-8049(94)00342-3. [DOI] [PubMed] [Google Scholar]
  12. Lipponen P. Apoptosis in breast cancer: relationship with other pathological parameters. Endocr Relat Cancer. 1999 Mar;6(1):13–16. doi: 10.1677/erc.0.0060013. [DOI] [PubMed] [Google Scholar]
  13. Mainwaring P. N., Ellis P. A., Detre S., Smith I. E., Dowsett M. Comparison of in situ methods to assess DNA cleavage in apoptotic cells in patients with breast cancer. J Clin Pathol. 1998 Jan;51(1):34–37. doi: 10.1136/jcp.51.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matter A. Microcinematographic and electron microscopic analysis of target cell lysis induced by cytotoxic T lymphocytes. Immunology. 1979 Feb;36(2):179–190. [PMC free article] [PubMed] [Google Scholar]
  15. Potten C. S. What is an apoptotic index measuring? A commentary. Br J Cancer. 1996 Dec;74(11):1743–1748. doi: 10.1038/bjc.1996.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rich T., Allen R. L., Wyllie A. H. Defying death after DNA damage. Nature. 2000 Oct 12;407(6805):777–783. doi: 10.1038/35037717. [DOI] [PubMed] [Google Scholar]
  17. Rochaix P., Krajewski S., Reed J. C., Bonnet F., Voigt J. J., Brousset P. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis. J Pathol. 1999 Mar;187(4):410–415. doi: 10.1002/(SICI)1096-9896(199903)187:4<410::AID-PATH266>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  18. Sanderson C. J. The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography. Proc R Soc Lond B Biol Sci. 1976 Jan 20;192(1107):241–255. doi: 10.1098/rspb.1976.0011. [DOI] [PubMed] [Google Scholar]
  19. Sarasin A., Stary A. Human cancer and DNA repair-deficient diseases. Cancer Detect Prev. 1997;21(5):406–411. [PubMed] [Google Scholar]
  20. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000 Oct 12;407(6805):784–788. doi: 10.1038/35037722. [DOI] [PubMed] [Google Scholar]
  21. Streuli C. H., Gilmore A. P. Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. J Mammary Gland Biol Neoplasia. 1999 Apr;4(2):183–191. doi: 10.1023/a:1018729308878. [DOI] [PubMed] [Google Scholar]
  22. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 1995 Mar 10;267(5203):1456–1462. doi: 10.1126/science.7878464. [DOI] [PubMed] [Google Scholar]
  23. Vakkala M., Lähteenmäki K., Raunio H., Päkkö P., Soini Y. Apoptosis during breast carcinoma progression. Clin Cancer Res. 1999 Feb;5(2):319–324. [PubMed] [Google Scholar]
  24. Vaux D. L., Korsmeyer S. J. Cell death in development. Cell. 1999 Jan 22;96(2):245–254. doi: 10.1016/s0092-8674(00)80564-4. [DOI] [PubMed] [Google Scholar]
  25. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  26. Zhang G. J., Kimijima I., Abe R., Watanabe T., Kanno M., Hara K., Tsuchiya A. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Res. 1998 May-Jun;18(3B):1989–1998. [PubMed] [Google Scholar]
  27. Zheng W. Q., Zhan R. Z. Quantitative comparison of apoptosis to cell proliferation and p53 protein in breast carcinomas. Anal Quant Cytol Histol. 1998 Feb;20(1):1–6. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES